[1]
Ventola, C.L. The antibiotic resistance crisis: part 1: causes and threats. P&T, 2015, 40(4), 277-283.
[2]
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet, 2022, 399(10325), 629-655.
[3]
Schcolnik-Cabrera, A.; Juarez-Lopez, D.; Duenas-Gonzalez, A. Perspectives on drug repurposing. Curr. Med. Chem., 2021, 28(11), 2085-2099.
[4]
Cuetero-Martinez, Y.; Cobos-Vasconcelos, D.L.; Aguirre-Garrido, J.F.; Lopez-Vidal, Y.; Noyola, A. Next-generation sequencing for surveillance of antimicrobial resistance and pathogenicity in municipal wastewater treatment plants. Curr. Med. Chem., 2023, 30, 5-29.
[5]
Cuevas-Cruz, M.; Hernandez-Guzman, U.; Alvarez-Rosales, P.C.; Schnabel, M.; Gomez-Manzo, S.; Arreguin-Espinosa, R. The role of mass spectrometry in the discovery of antibiotics and bacterial resistance mechanisms: proteomics and metabolomics approaches. Curr. Med. Chem., 2023, 30, 30-58.
[6]
Schcolnik-Cabrera, A.; Dominguez-Gomez, G.; Chavez-Blanco, A.; Ramirez-Yautentzi, M.; Morales-Barcenas, R.; Chavez-Diaz, J.; Taja-Chayeb, L.; Dueaas-Gonzalez, A. A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells. Oncol. Lett., 2019, 18(6), 6909-6916.
[7]
Canturri, A.M.; Smani, Y. Anthelmintic drugs for repurposing against Gram-negative bacilli infections. Curr. Med. Chem., 2023, 30, 59-71.
[8]
Al Salman, J.; Al Dabal, L.; Bassetti, M.; Alfouzan, W.A.; Al Maslamani, M.; Alraddadi, B.; Elhoufi, A.; Enani, M.; Khamis, F.A.; Mokkadas, E. Management of infections caused by WHO critical priority Gram-negative pathogens in Arab countries of the Middle East: a consensus paper. Int. J. Antimicrob. Agents, 2020, 56(4), 106104.
[9]
Juarez-Lopez, D.; Morales-Ruiz, E.; Herrera-Zuniga, L.D.; Gonzalez-Carrera, Z.; Cuevas-Reyes, E.; Corzo, G.; Schcolnik-Cabrera, A.; Villegas, E. The resilience of Pseudomonas aeruginosa to antibiotics, and the designing of antimicrobial peptides to overcome microbial resistance. Curr. Med. Chem., 2023, 30, 72-103.
[10]
Kuppusamy, R.; Browne, K.; Suresh, D.; Do Rosario, R.M.; Chakraborty, S.; Yang, S.; Willcox, M.D.; Black, D.S.; Chen, R.; Kumar, N. Transition towards antibiotic hybrid vehicles: the next generation antibacterials. Curr. Med. Chem., 2023, 30, 104-125.
